The NCRI Lymphoma Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of lymphoma. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for lymphoma patients.  

The NCRI Lymphoma Group consists of an executive group, chaired by Professor Andrew Pettittwhich provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI Lymphoma Group also has several subgroups that develop research in areas of strategic need. 

How can I get involved?

Join the NCRI Lymphoma Network

Group members

Professor Andrew Pettitt

Chair

I studied Medicine at Cambridge (1983-1989) before taking up clinical training posts in Internal ...

Professor Andrew Pettitt

Chair

I studied Medicine at Cambridge (1983-1989) before taking up clinical training posts in Internal Medicine (Nottingham, 1990-1992) and Haematology (Liverpool, 1992-2000), during which time I completed a PhD on drug resistance in chronic lymphocytic leukaemia (CLL). In 2000, I was appointed as Clinical Senior Lecturer in Haematology at the University of Liverpool, with subsequent promotion to Reader (2004), Personal Chair (2006) and Ronald Finn Professor of Experimental Medicine (2013).